Literature DB >> 9231822

The sympathetic nervous system is involved in the maintenance but not initiation of the hypertension induced by N(omega)-nitro-L-arginine methyl ester.

M Sander1, J Hansen, R G Victor.   

Abstract

Studies in anesthetized animals have advanced the theory that there is an important neurogenic component to the hypertension caused by pharmacological inhibition of nitric oxide, but studies in conscious animals have produced conflicting evidence for and against this theory. To try to reconcile the seemingly contradictory data, we hypothesized that the neurogenic component of this hypertension is time dependent such that the sympathetic nervous system is involved primarily in the maintenance, rather than the initiation, of the hypertension. We measured intra-arterial pressure in conscious, unrestrained rats with and without guanethidine-induced sympathectomy during varying durations of intravenous N(omega)-nitro-L-arginine methyl ester (L-NAME). The major new finding is that sympathectomy had no effect on the hypertensive response to bolus injections of L-NAME but in the same rats it produced a greater than 50% attenuation in the hypertension seen after 6 days of continuous L-NAME (change in mean arterial pressure, 23+/-4 versus 55+/-4 mm Hg, P<.01, sympathectomy versus control). Using 8-hour infusions of L-NAME, we found that 60 minutes was the minimum time required for detecting a sympathectomy-sensitive component of L-NAME-induced hypertension. Furthermore, we demonstrate that the magnitude of this component increases further between 8 hours to 6 days of continuous L-NAME: it accounted for only 18% of the total hypertensive response at 8 hours but 61% after 6 days. From these experiments, we conclude that the importance of the sympathetic system in the pathogenesis of L-NAME-induced hypertension accrues slowly over hours and days, and thus its importance can be overlooked by focusing on the initial phase of the hypertension.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231822     DOI: 10.1161/01.hyp.30.1.64

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  19 in total

1.  Sympathetic nerves and the progression of chronic kidney disease during 5/6 nephrectomy: studies in sympathectomized rats.

Authors:  Robert A Augustyniak; Maria M Picken; David Leonard; Xin J Zhou; Weiguo Zhang; Ronald G Victor
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-06-29       Impact factor: 2.557

Review 2.  Chronic nitric oxide inhibition model six years on.

Authors:  R Zatz; C Baylis
Journal:  Hypertension       Date:  1998-12       Impact factor: 10.190

Review 3.  Carotid baroreflex activation therapy for resistant hypertension.

Authors:  Ronald G Victor
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

4.  Nitric oxide-mediated central sympathetic excitation promotes CNS and pulmonary O₂ toxicity.

Authors:  Ivan T Demchenko; Alexander N Moskvin; Alexander I Krivchenko; Claude A Piantadosi; Barry W Allen
Journal:  J Appl Physiol (1985)       Date:  2012-03-22

5.  Normalization of supine blood pressure after nitric oxide synthase inhibition in persons with tetraplegia.

Authors:  Jill M Wecht; Joseph P Weir; AnnMarie H Krothe; Ann M Spungen; William A Bauman
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

Review 6.  Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension.

Authors:  Agustin Gonzalez-Vicente; Fara Saez; Casandra M Monzon; Jessica Asirwatham; Jeffrey L Garvin
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

Review 7.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

Review 8.  Blood pressure regulation VIII: resistance vessel tone and implications for a pro-atherogenic conduit artery endothelial cell phenotype.

Authors:  Jaume Padilla; Nathan T Jenkins; M Harold Laughlin; Paul J Fadel
Journal:  Eur J Appl Physiol       Date:  2013-07-17       Impact factor: 3.078

Review 9.  Central sympathetic overactivity: maladies and mechanisms.

Authors:  James P Fisher; Colin N Young; Paul J Fadel
Journal:  Auton Neurosci       Date:  2009-03-06       Impact factor: 3.145

10.  Central and peripheral haemodynamic effects of L-NAME infusion in healthy volunteers.

Authors:  D R Morgan; B Silke; L J Dixon; P B Allen; C G Hanratty; G E McVeigh
Journal:  Eur J Clin Pharmacol       Date:  2003-05-17       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.